IOL CHEMICALS AND PHARMACEUTICALS
|
IOL CHEMICALS AND PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
| Equity - Authorised | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr |
| Equity - Issued | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
| Equity Paid Up | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹1,740 Cr | ₹1,629 Cr | ₹1,553 Cr | ₹1,449 Cr | ₹1,334 Cr |
| Securities Premium | ₹226 Cr | ₹226 Cr | ₹226 Cr | ₹226 Cr | ₹226 Cr |
| Capital Reserves | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
| Profit & Loss Account Balance | ₹1,510 Cr | ₹1,402 Cr | ₹1,324 Cr | ₹1,219 Cr | ₹1,104 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | ₹-7.00 Cr | ₹-9.60 Cr | ₹-8.16 Cr | ₹-6.87 Cr | ₹-6.67 Cr |
| Reserve excluding Revaluation Reserve | ₹1,740 Cr | ₹1,629 Cr | ₹1,553 Cr | ₹1,449 Cr | ₹1,334 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹1,799 Cr | ₹1,688 Cr | ₹1,612 Cr | ₹1,508 Cr | ₹1,392 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹85 Cr | ₹78 Cr | ₹66 Cr | ₹56 Cr | ₹53 Cr |
| Deferred Tax Assets | ₹6.96 Cr | ₹4.97 Cr | ₹4.56 Cr | ₹3.97 Cr | ₹2.91 Cr |
| Deferred Tax Liability | ₹92 Cr | ₹83 Cr | ₹71 Cr | ₹60 Cr | ₹56 Cr |
| Other Long Term Liabilities | ₹2.40 Cr | - | ₹0.04 Cr | ₹0.14 Cr | ₹0.43 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹11 Cr | ₹6.69 Cr | ₹6.71 Cr | ₹1.65 Cr | ₹3.01 Cr |
| Total Non-Current Liabilities | ₹98 Cr | ₹85 Cr | ₹73 Cr | ₹58 Cr | ₹57 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹483 Cr | ₹428 Cr | ₹469 Cr | ₹314 Cr | ₹409 Cr |
| Sundry Creditors | ₹483 Cr | ₹428 Cr | ₹469 Cr | ₹314 Cr | ₹409 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹70 Cr | ₹63 Cr | ₹55 Cr | ₹54 Cr | ₹54 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹11 Cr | ₹8.33 Cr | ₹8.85 Cr | ₹7.44 Cr | ₹14 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹59 Cr | ₹55 Cr | ₹46 Cr | ₹47 Cr | ₹40 Cr |
| Short Term Borrowings | ₹132 Cr | ₹117 Cr | ₹33 Cr | ₹80 Cr | ₹43 Cr |
| Secured ST Loans repayable on Demands | ₹132 Cr | ₹117 Cr | ₹33 Cr | ₹80 Cr | ₹43 Cr |
| Working Capital Loans- Sec | ₹132 Cr | ₹117 Cr | ₹33 Cr | ₹80 Cr | ₹43 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-132 Cr | ₹-117 Cr | ₹-33 Cr | ₹-80 Cr | ₹-43 Cr |
| Short Term Provisions | ₹49 Cr | ₹31 Cr | ₹40 Cr | ₹54 Cr | ₹69 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹46 Cr | ₹29 Cr | ₹37 Cr | ₹46 Cr | ₹62 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹3.42 Cr | ₹1.97 Cr | ₹3.39 Cr | ₹8.13 Cr | ₹7.34 Cr |
| Total Current Liabilities | ₹733 Cr | ₹639 Cr | ₹597 Cr | ₹503 Cr | ₹575 Cr |
| Total Liabilities | ₹2,630 Cr | ₹2,411 Cr | ₹2,282 Cr | ₹2,068 Cr | ₹2,024 Cr |
| ASSETS | |||||
| Gross Block | ₹1,632 Cr | ₹1,544 Cr | ₹1,236 Cr | ₹995 Cr | ₹762 Cr |
| Less: Accumulated Depreciation | ₹451 Cr | ₹374 Cr | ₹303 Cr | ₹243 Cr | ₹201 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹1,182 Cr | ₹1,171 Cr | ₹933 Cr | ₹752 Cr | ₹561 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹94 Cr | ₹21 Cr | ₹100 Cr | ₹81 Cr | ₹102 Cr |
| Non Current Investments | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr | - |
| Long Term Investment | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr | - |
| Quoted | - | - | - | - | - |
| Unquoted | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr | - |
| Long Term Loans & Advances | ₹20 Cr | ₹12 Cr | ₹24 Cr | ₹9.52 Cr | ₹11 Cr |
| Other Non Current Assets | ₹45 Cr | ₹8.53 Cr | ₹50 Cr | ₹233 Cr | ₹205 Cr |
| Total Non-Current Assets | ₹1,359 Cr | ₹1,231 Cr | ₹1,125 Cr | ₹1,102 Cr | ₹881 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹3.51 Cr | ₹3.30 Cr | ₹2.88 Cr | ₹2.56 Cr | ₹2.37 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹3.51 Cr | ₹3.30 Cr | ₹2.88 Cr | ₹2.56 Cr | ₹2.37 Cr |
| Inventories | ₹371 Cr | ₹361 Cr | ₹425 Cr | ₹326 Cr | ₹410 Cr |
| Raw Materials | ₹159 Cr | ₹168 Cr | ₹194 Cr | ₹134 Cr | ₹243 Cr |
| Work-in Progress | ₹47 Cr | ₹39 Cr | ₹45 Cr | ₹62 Cr | ₹60 Cr |
| Finished Goods | ₹113 Cr | ₹100 Cr | ₹117 Cr | ₹60 Cr | ₹48 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹17 Cr | ₹16 Cr | ₹21 Cr | ₹20 Cr | ₹14 Cr |
| Other Inventory | ₹35 Cr | ₹37 Cr | ₹48 Cr | ₹50 Cr | ₹45 Cr |
| Sundry Debtors | ₹603 Cr | ₹514 Cr | ₹471 Cr | ₹505 Cr | ₹470 Cr |
| Debtors more than Six months | ₹10 Cr | ₹8.29 Cr | ₹6.01 Cr | ₹10 Cr | ₹20 Cr |
| Debtors Others | ₹597 Cr | ₹508 Cr | ₹467 Cr | ₹496 Cr | ₹451 Cr |
| Cash and Bank | ₹198 Cr | ₹208 Cr | ₹143 Cr | ₹22 Cr | ₹140 Cr |
| Cash in hand | ₹0.60 Cr | ₹0.78 Cr | ₹0.88 Cr | ₹0.53 Cr | ₹0.42 Cr |
| Balances at Bank | ₹198 Cr | ₹207 Cr | ₹142 Cr | ₹21 Cr | ₹140 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹30 Cr | ₹27 Cr | ₹25 Cr | ₹30 Cr | ₹31 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | ₹2.90 Cr | ₹1.65 Cr | ₹3.12 Cr | ₹0.91 Cr | ₹3.42 Cr |
| Prepaid Expenses | ₹9.26 Cr | ₹7.89 Cr | ₹13 Cr | ₹8.21 Cr | ₹7.90 Cr |
| Other current_assets | ₹18 Cr | ₹17 Cr | ₹8.36 Cr | ₹21 Cr | ₹20 Cr |
| Short Term Loans and Advances | ₹65 Cr | ₹67 Cr | ₹90 Cr | ₹82 Cr | ₹90 Cr |
| Advances recoverable in cash or in kind | ₹6.01 Cr | ₹7.40 Cr | ₹8.31 Cr | ₹9.10 Cr | ₹5.77 Cr |
| Advance income tax and TDS | ₹43 Cr | ₹29 Cr | ₹44 Cr | ₹48 Cr | ₹63 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹15 Cr | ₹31 Cr | ₹38 Cr | ₹24 Cr | ₹21 Cr |
| Total Current Assets | ₹1,271 Cr | ₹1,180 Cr | ₹1,157 Cr | ₹967 Cr | ₹1,143 Cr |
| Net Current Assets (Including Current Investments) | ₹537 Cr | ₹541 Cr | ₹560 Cr | ₹464 Cr | ₹567 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹2,630 Cr | ₹2,411 Cr | ₹2,282 Cr | ₹2,068 Cr | ₹2,024 Cr |
| Contingent Liabilities | ₹5.66 Cr | ₹5.52 Cr | ₹6.08 Cr | ₹5.35 Cr | ₹0.18 Cr |
| Total Debt | ₹132 Cr | ₹117 Cr | ₹33 Cr | ₹80 Cr | ₹43 Cr |
| Book Value | - | 57.49 | 274.49 | 256.81 | 237.15 |
| Adjusted Book Value | 61.27 | 57.49 | 54.90 | 51.36 | 47.43 |
Compare Balance Sheet of peers of IOL CHEMICALS AND PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IOL CHEMICALS AND PHARMACEUTICALS | ₹4,685.7 Cr | 0.9% | 2.7% | 79% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
IOL CHEMICALS AND PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IOL CHEMICALS AND PHARMACEUTICALS | 0.9% |
2.7% |
79% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses